Abstract:Background: The staging of primary lower extremity lymphedema (LEL) is difficult yet vital in clinical work, and magnetic resonance imaging (MRI) can be used for quantitative assessment of primary LEL due to its high resolution for soft tissues. In this study, we evaluated the value of MRI-based soft tissue area measurements for staging primary LEL.Methods: A total of 90 consecutive patients with clinically diagnosed primary lower limb lymphoedema from January 2017 to December 2019 in Beijing Shijitan Hospital were enrolled retrospectively. Short time inversion recovery (STIR) sequence was applied to measure the total, muscle, bone, and subcutaneous areas in the upper 1/3 level of the bilateral lower calf. The difference between the affected and unaffected calf regarding the subcutaneous area was obtained, and (subcutaneous area)/(bone area) and (subcutaneous area)/ (muscle area) were calculated. According to the International Society of Lymphology (ISL) clinical staging standard established in 2020, all patients were divided into stages I, II, and III, accordingly. Statistical analysis was performed to determine the validity of MRI measurements in staging LEL.Results: There were 33 patients classified as stage I clinically, 44 patients as stage II, and 13 patients as stage III. There were significant differences in total, subcutaneous, the difference in subcutaneous area of limbs, subcutaneous/bone (S/B), and subcutaneous/muscle (S/M) between stage I and II as well as between stage I and III (P<0.001), but not between stage II and III (P=0.706, 0.329, and 0.229, respectively). A positive correlation was detected between the clinical stage and difference in subcutaneous area of limbs (rho =0.752, P<0.001), S/B (rho =0.747, P<0.001), S/M (rho =0.709, P<0.001), and subcutaneous (rho =0.723, P<0.001). For staging primary LEL, receiver operating characteristic (ROC) curves indicated that the difference in subcutaneous area of limbs had the best discrimination ability among parameters [area under the ROC curve (AUC) =0.950; 95% confidence interval (CI): 0.875-0.987; sensitivity: 95.45%; specificity: 84.85%], followed by S/B (AUC =0.930; 95% CI: 0.848-0.975; sensitivity: 77.27%; specificity: 93.94%) and S/M (AUC =0.895; 95% CI: 0.804-0.953; sensitivity: 77.27%; specificity: 90.91%). The ROC curves indicated that subcutaneous area (AUC =0.927; 95% CI: 0.844-0.974; sensitivity: 84.09%, specificity: 90.91%) and total (AUC =0.852; 95% CI: 0.753-0.923; sensitivity: 70.45%; specificity: 90.91%) also had discrimination ability between stage I and II. Conclusions: The measurement of the soft tissue area of the calf may be used as an auxiliary method for staging primary LEL. For patients with unilateral primary LEL, the difference in subcutaneous area of limbs could be a specific indicator to distinguish clinical stage I from II.

Magnetic resonance lymphography findings across different clinical stages of lower limb lymphedema

MRI Features of Primary Lower Extremity Lymphedema: a Retrospective Analysis of 228 Patients

Magnetic Resonance Lymphography of Lymphatic Vessels in Upper Extremity with Breast Cancer–Related Lymphedema

MR Lymphography of Lymphatic Vessels in Lower Extremity with Gynecologic Oncology-Related Lymphedema.

The assessment of lymphatic system in lymphedema with magnetic resonance lymphangiography

Interstitial MR Lymphangiography Ha Patients with Lower Extremity Lymphedema: a Preliminary Report

Magnetic Resonance Lymphangiography for the Study of Lymphatic System in Lymphedema

Chronic Lower Extremity Lymphedema: A Comparative Study of High-Resolution Interstitial Mr Lymphangiography and Heavily T2-Weighted Mri

Edema Areas of Calves Measured with Magnetic Resonance Imaging as a Novel Indicator for Early Staging of Lower Extremity Lymphedema.

The Comparative Study of Interstitial MR Lymphography and Pathological Findings in Limb Lymph Edema: An Experimental Study in Rabbits

Quantitative Evaluation of Primary Lower Extremity Lymphedema Staging Using MRI: a Preliminary Study

Thickness of soft tissue of lower extremities measured with magnetic resonance imaging as a new indicator for staging unilateral secondary lower extremity lymphedema.

Assessment of the Lymphatic System of the Genitalia Using Magnetic Resonance Lymphography Before and after Treatment of Male Genital Lymphedema

Comparison of Radionuclide Lymphoscintigraphy and Dynamic Magnetic Resonance Lymphangiography for Investigating Extremity Lymphoedema

The Technical Methods in MR Lymphographic Experimental Study on Limb Lymph Edema

Three-dimensional non-contrast magnetic resonance lymphography severity stage for upper extremity lymphedema

Clinical Application of Magnetic Resonance Lymphangiography in the Vascularized Omental Lymph Nodes Transfer with or Without Lymphaticovenous Anastomosis for Cancer-Related Lower Extremity Lymphedema.

The Experimental Study on Lymphography

Magnetic Resonance Lymphography Demonstrates Spontaneous Lymphatic Disruption and Regeneration in Obstructive Lymphedema.

The Value of the Dermal Rim Sign on Nonenhanced MRI for Predicting Dermal Backflow in Patients with Primary Lower Extremity Lymphedema

MRI features of lymphedema of lower extremity